BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of GBP 914.07 million. The enterprise value is 849.77 million.
| Market Cap | 914.07M |
| Enterprise Value | 849.77M |
Important Dates
The next confirmed earnings date is Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | May 8, 2025 |
Share Statistics
| Current Share Class | 98.50M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.89% |
| Owned by Institutions (%) | 42.24% |
| Float | 67.99M |
Valuation Ratios
The trailing PE ratio is 34.08 and the forward PE ratio is 27.12.
| PE Ratio | 34.08 |
| Forward PE | 27.12 |
| PS Ratio | 7.37 |
| PB Ratio | 8.63 |
| P/TBV Ratio | 9.72 |
| P/FCF Ratio | 37.42 |
| P/OCF Ratio | 36.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.22, with an EV/FCF ratio of 34.79.
| EV / Earnings | 31.68 |
| EV / Sales | 6.88 |
| EV / EBITDA | 22.22 |
| EV / EBIT | 23.43 |
| EV / FCF | 34.79 |
Financial Position
The company has a current ratio of 6.12
| Current Ratio | 6.12 |
| Quick Ratio | 4.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 74.62 |
Financial Efficiency
Return on equity (ROE) is 21.91% and return on invested capital (ROIC) is 71.21%.
| Return on Equity (ROE) | 21.91% |
| Return on Assets (ROA) | 15.56% |
| Return on Invested Capital (ROIC) | 71.21% |
| Return on Capital Employed (ROCE) | 32.31% |
| Weighted Average Cost of Capital (WACC) | 6.59% |
| Revenue Per Employee | 512,361 |
| Profits Per Employee | 110,843 |
| Employee Count | 242 |
| Asset Turnover | 0.85 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioGaia AB has paid 7.13 million in taxes.
| Income Tax | 7.13M |
| Effective Tax Rate | 21.00% |
Stock Price Statistics
The stock price has decreased by -2.30% in the last 52 weeks. The beta is 0.43, so BioGaia AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -2.30% |
| 50-Day Moving Average | 109.63 |
| 200-Day Moving Average | 104.30 |
| Relative Strength Index (RSI) | 55.29 |
| Average Volume (20 Days) | 22,382 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of GBP 123.99 million and earned 26.82 million in profits. Earnings per share was 0.27.
| Revenue | 123.99M |
| Gross Profit | 90.97M |
| Operating Income | 36.43M |
| Pretax Income | 33.95M |
| Net Income | 26.82M |
| EBITDA | 38.42M |
| EBIT | 36.43M |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 64.59 million in cash and n/a in debt, with a net cash position of 64.59 million.
| Cash & Cash Equivalents | 64.59M |
| Total Debt | n/a |
| Net Cash | 64.59M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 105.94M |
| Book Value Per Share | 1.05 |
| Working Capital | 82.22M |
Cash Flow
In the last 12 months, operating cash flow was 24.71 million and capital expenditures -284,069, giving a free cash flow of 24.43 million.
| Operating Cash Flow | 24.71M |
| Capital Expenditures | -284,069 |
| Depreciation & Amortization | 1.98M |
| Net Borrowing | -549,385 |
| Free Cash Flow | 24.43M |
| FCF Per Share | n/a |
Margins
Gross margin is 73.37%, with operating and profit margins of 29.38% and 21.63%.
| Gross Margin | 73.37% |
| Operating Margin | 29.38% |
| Pretax Margin | 27.38% |
| Profit Margin | 21.63% |
| EBITDA Margin | 30.99% |
| EBIT Margin | 29.38% |
| FCF Margin | 19.70% |
Dividends & Yields
This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.47%.
| Dividend Per Share | 0.54 |
| Dividend Yield | 0.47% |
| Dividend Growth (YoY) | 5.77% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 209.76% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 0.38% |
| Earnings Yield | 2.93% |
| FCF Yield | 2.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |